SomaLogic (SLGCW)

Profile

Full Name

SomaLogic, Inc.

Ticker Symbol

SLGCW

Exchange

NASDAQ

Sector

Healthcare

Industry

Health Information Services

Country

United States

IPO

Indexes

Not included

Website

http://www.somalogic.com

Employees

451

Key Details

Price

$0.09

Market cap

-

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$97.67M(+19.65% YoY)

Annual EPS

-

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.09
SLGCW price is $0.09

30-Day Relative Volume

0.40
SLGCW 30-day relative volume is 0.40

Price Performance

Price Most recent change

-
SLGCW price change on Apr 1, 2025 is unknown

Price YTD change

-
SLGCW price ytd change is unknown

Price 1-year change

-
SLGCW price 1-year change is unknown

Price 3-year change

-
SLGCW price 3-year change is unknown

Price Range

Price All-time high

$0.79
SLGCW price is currently -89.05% below its historical high of $0.79

Price 3-year low

$0.08
SLGCW price is currently +7.50% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

-
SLGCW market capitalization value is unknown

Market cap 3-year change

-
SLGCW market capitalization 3-year change is unknown

Market cap All-time high

-
SLGCW market capitalization all-time high is unknown

Market cap sector rank

-
SLGCW market capitalization is unknown

Shares Outstanding

Shares Outstanding 1-Year Change

-
SLGCW shares outstanding 1-year change is unknown

Shares Outstanding 3-Year Change

-
SLGCW shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

-
SLGCW beta value is unknown

200-day SMA

$0.09
SLGCW price is currently equal to its 200-day simple moving average

50-day SMA

$0.09
SLGCW price is currently equal to its 50-day simple moving average

RSI

-
SLGCW 14-day relative strength index value is unknown

Volume

0.40
SLGCW 30-day relative volume is 0.40

ATR

-
SLGCW average true range value is unknown

10-day Historical Volatility

-
SLGCW 10-day historical volatility value is unknown

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$97.67M
SLGCW annual revenue is $97.67 million

Revenue Analysts estimate

-
SLGCW annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

+19.65%
SLGCW annual revenue is up +19.65% year-on-year

Revenue Sector rank

56.1%
SLGCW annual revenue is higher than 56.1% of companies in Healthcare sector

EPS

EPS

-
SLGCW annual earnings per share value is unknown

EPS Analysts estimate

-
SLGCW annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

-
SLGCW annual earnings per share 1-year change is unknown

EPS Sector rank

-
SLGCW annual earnings per share is unknown

Profit

Gross profit

$54.30M
SLGCW annual gross profit is $54.30 million

Gross margin

55.60%
SLGCW annual gross profit margin is 55.60%

Operating profit

-$175.76M
SLGCW annual operating income is -$175.76 million

Operating margin

-179.96%
SLGCW annual operating profit margin is -179.96%

Net income

-$109.16M
SLGCW annual net profit is -$109.16 million

Net margin

-
SLGCW annual net profit margin value is unknown

Expenses

Total expenses

$273.43M
SLGCW annual total expenses is $273.43 million

Operating expenses

$230.06M
SLGCW annual total operating expenses is $230.06 million

Cost of goods sold

$43.36M
SLGCW annual cost of goods sold is $43.36 million

Selling, general & administrative expenses

$156.62M
SLGCW annual SGA is $156.62 million

Depreciation and amortization

$4.57M
SLGCW annual depreciation & amortization is $4.57 million

Interest expense

$0.00
SLGCW annual interest expense is $0.00

Income tax

-$717.00K
SLGCW annual income tax is -$717.00 thousand

EBIT & EBITDA

EBIT

-$109.87M
SLGCW annual earnings before interest & taxes is -$109.87 million

EBITDA

-$163.14M
SLGCW annual EBITDA is -$163.14 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$647.37M
SLGCW annual total assets is $647.37 million

Non current assets

$65.67M
SLGCW annual long term assets is $65.67 million

Current assets

$581.70M
SLGCW annual total current assets is $581.70 million

Cash and cash equivalents

$421.83M
SLGCW annual cash & cash equivalents is $421.83 million

Accounts receivable

$17.01M
SLGCW annual accounts receivable is $17.01 million

Inventory

$13.90M
SLGCW annual inventory is $13.90 million

Liabilities

Total liabilities

$84.82M
SLGCW annual total liabilities is $84.82 million

Long term liabilities

$41.48M
SLGCW annual total long term liabilities is $41.48 million

Current liabilities

$43.33M
SLGCW annual total current liabilities is $43.33 million

Accounts payable

$16.79M
SLGCW annual accounts payable is $16.79 million

Debt

Total debt

$2.48M
SLGCW annual total debt is $2.48 million

Total debt 1-year change

+3653.03%
SLGCW annual total debt is up +3653.03% year-on-year

Long term debt

-
SLGCW annual long term debt value is unknown

Short term debt

-
SLGCW annual short term debt value is unknown

Equity & Capital

Shareholders equity

$562.56M
SLGCW annual stockholders equity is $562.56 million

Book value

$535.46M
SLGCW annual book value is $535.46 million

Retained earnings

-$608.07M
SLGCW annual retained earnings is -$608.07 million

Working capital

$538.37M
SLGCW annual working capital is $538.37 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$100.67M
SLGCW annual cash flow from operations is -$100.67 million

Cash from operations 1-year change

-149.28%
SLGCW annual cash flow from operations is down -149.28% year-on-year

Cash from investing

$82.54M
SLGCW annual cash flow from investing activities is $82.54 million

Cash from investing 1-year change

+145.35%
SLGCW annual cash flow from investing activities is up +145.35% year-on-year

Cash from financing

$5.18M
SLGCW annual cash flow from financing activities is $5.18 million

Cash from financing 1-year change

-98.96%
SLGCW annual cash flow from financing activities is down -98.96% year-on-year

CAPEX

CAPEX

$5.21M
SLGCW annual capital expenditures is $5.21 million

CAPEX 1-year change

+57.7%
SLGCW annual capital expenditures is up +57.7% year-on-year

Free Cash Flow

Free cash flow

-$105.88M
SLGCW annual free cash flow is -$105.88 million

Free cash flow 1-year change

-142.35%
SLGCW annual free cash flow is down -142.35% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

55.60%
SLGCW annual gross profit margin is 55.60%

Operating margin

-179.96%
SLGCW annual operating profit margin is -179.96%

Net margin

-
SLGCW annual net profit margin value is unknown

ROA & ROE

ROA

-16.86%
SLGCW annual return on assets is -16.86%

ROE

-19.40%
SLGCW annual return on equity is -19.40%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
SLGCW price to earnings ratio value is unknown

PE ratio Sector rank

-
SLGCW price to earnings ratio is unknown

PB Ratio

PB ratio

-
SLGCW price to book ratio value is unknown

PB ratio Sector rank

-
SLGCW price to book ratio is unknown

PS Ratio

PS ratio

-
SLGCW price to sales ratio value is unknown

PS ratio Sector rank

-
SLGCW price to sales ratio is unknown

Enterprise value

Enterprise value

-
SLGCW enterprise value value is unknown

Enterprise value Sector rank

-
SLGCW enterprise value is unknown

EV/EBITDA

EV/EBITDA

-
SLGCW EV/EBITDA value is unknown

EV/EBITDA Sector rank

-
SLGCW EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

13.42
SLGCW annual current ratio is 13.42

Quick ratio

13.10
SLGCW annual quick ratio is 13.10

Leverage

Debt to equity

0.00
SLGCW annual debt to equity ratio is 0.00

Interest coverage ratio

-
SLGCW annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
SLGCW piotroski f-score value is unknown

Altman Z-Score

-
SLGCW altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Oct 5, 23 Jefferies
Hold
Sep 25, 23 Canaccord Genuity
Hold
Mar 29, 23 TD Cowen
Outperform
Mar 29, 23 Stifel
Buy
Mar 29, 23 Canaccord Genuity
Buy
Aug 16, 22 Cowen & Co.
Outperform
Jun 23, 22 Cowen & Co.
Outperform
May 13, 22 Canaccord Genuity
Buy
Feb 1, 22 Stifel
Buy
Dec 14, 21 Canaccord Genuity
Buy

Institutional Ownership

Similar stocks

  • What is the ticker symbol for SomaLogic?
  • Does SomaLogic pay dividends?
  • What sector is SomaLogic in?
  • What industry is SomaLogic in?
  • What country is SomaLogic based in?
  • Is SomaLogic in the S&P 500?
  • Is SomaLogic in the NASDAQ 100?
  • Is SomaLogic in the Dow Jones?
  • When does SomaLogic report earnings?

What is the ticker symbol for SomaLogic?

The ticker symbol for SomaLogic is NASDAQ:SLGCW

Does SomaLogic pay dividends?

No, SomaLogic does not pay dividends

What sector is SomaLogic in?

SomaLogic is in the Healthcare sector

What industry is SomaLogic in?

SomaLogic is in the Health Information Services industry

What country is SomaLogic based in?

SomaLogic is headquartered in United States

Is SomaLogic in the S&P 500?

No, SomaLogic is not included in the S&P 500 index

Is SomaLogic in the NASDAQ 100?

No, SomaLogic is not included in the NASDAQ 100 index

Is SomaLogic in the Dow Jones?

No, SomaLogic is not included in the Dow Jones index

When does SomaLogic report earnings?

The date for SomaLogic's next earnings report has not been announced yet
On this page